Drug & Biologic Guidance Watch keeps you up-to-date each week with the latest official thinking of key regulators around the world for a fraction of the cost of other trade publications.

In an increasingly global market place, you must know what regulators are thinking and that means following the guidance. Your day-to-day research, manufacturing and marketing activities are heavily influenced by these formal and draft guidances issued and adopted by regulators.

But why spend hundreds and thousands of dollars on consultants and newsletters that only guess about what key regulators in the U.S., E.U., Canada, Australia, WHO and elsewhere are thinking when you can see the reality for yourself?

But first, you must know these document exist and get them. That can take a lot of time, effort and experience. Drug & Biologic Guidance Watch is edited by Dennis Melamed, a veteran pharmaceutical journalist with more than 20 years of regulatory experience and a frequent speaker on regulatory issues. So you can be sure that you are getting the information and access to resources you need in a timely manner.

So go directly to the source and strengthen your compliance program cheaply with this cost-effective weekly service.